Free Trial

Acrivon Therapeutics (ACRV) Institutional Ownership

$8.55
-0.34 (-3.82%)
(As of 05/20/2024 ET)

Institutional Ownership Changes (13F Filings) for Acrivon Therapeutics (NASDAQ:ACRV)

Current
Institutional Ownership
Percentage
71.62%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$920.10K
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$781.28K
Get ACRV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acrivon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ACRV Institutional Buying and Selling by Quarter

Acrivon Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2024 Baker BROS. Advisors LP52,885$378K0.0%N/A0.234%
5/14/2024 American International Group Inc.6,016$43K0.0%+39.2%0.027%
5/10/2024 Vanguard Group Inc.507,185$3.63M0.0%+6.6%2.241%
1/5/2024 Exchange Traded Concepts LLC13,289$65K0.0%+34.0%0.060%
11/13/2023 Federated Hermes Inc.226,375$2.16M0.0%-25.6%1.020%
9/21/2023 Barclays PLC14,263$184K0.0%-16.0%0.065%
8/10/2023 AAF Wealth Management LLC10,678$138K0.1%N/A0.049%
7/20/2023 Exchange Traded Concepts LLC11,709$152K0.0%N/A0.053%
5/8/2023 Federated Hermes Inc.613,625$7.79M0.0%-25.5%2.798%
2/16/2023HealthCor Management L.P.284,201$3.27M3.0%N/A1.360%
2/14/2023 RA Capital Management L.P.4,810,508$55.42M1.1%N/A23.028%
2/13/2023 Sands Capital Ventures LLC1,652,605$19.04M5.2%N/A7.913%
2/10/2023 NEA Management Company LLC481,677$4.44M0.2%N/A2.306%
2/1/2023 Bank of Montreal Can42,444$545K0.0%N/A0.203%
(Data available from 1/1/2016 forward)

ACRV Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ACRV shares?

During the previous two years, 12 institutional investors and hedge funds held shares of Acrivon Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($55.42M), Sands Capital Ventures LLC ($19.04M), NEA Management Company LLC ($4.44M), Vanguard Group Inc. ($3.63M), HealthCor Management L.P. ($3.27M), Federated Hermes Inc. ($2.16M), and Bank of Montreal Can ($545K).Learn more on ACRV's institutional investors.

What percentage of Acrivon Therapeutics stock is owned by institutional investors?

71.62% of Acrivon Therapeutics stock is owned by institutional investors. Learn more on ACRV's institutional investor holdings.

Which institutional investors have been buying Acrivon Therapeutics stock?

Of the 10 institutional investors that purchased Acrivon Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.81M), Sands Capital Ventures LLC ($1.65M), NEA Management Company LLC ($481.68K), HealthCor Management L.P. ($284.20K), Baker BROS. Advisors LP ($52.89K), Bank of Montreal Can ($42.44K), and Vanguard Group Inc. ($31.21K).

How much institutional buying is happening at Acrivon Therapeutics?

Institutional investors have bought a total of 7,382,980 shares in the last 24 months. This purchase volume represents approximately $84.69M in transactions.

Which Acrivon Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Acrivon Therapeutics stock in the last 24 months: Federated Hermes Inc. ($287.71K), and Barclays PLC ($2.72K).

How much institutional selling is happening at Acrivon Therapeutics?

Institutional investors have sold a total of 290,431 shares in the last 24 months. This volume of shares sold represents approximately $3.44M in transactions.


This page (NASDAQ:ACRV) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners